Clinical trial · Observational
Customized TULSA-PRO Ablation Registry
NCT05001477CI-TRIAL-00082275CARErecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This patient registry will capture data from patients who have been or who are undergoing the transurethral ultrasound ablation (TULSA) procedure as part of their routine clinical care. The registry will shed light on real-world outcomes of safety and efficacy of the procedure and understand how a patient's quality of life is affected throughout their follow-up and lifetime.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Benign Prostatic Hyperplasia | Benign Prostatic Hyperplasia | ONTOLOGY_EXACT | 0.98 |
| Prostate Adenocarcinoma | Prostate Adenocarcinoma | ONTOLOGY_EXACT | 0.98 |
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| TULSA Procedure | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Rate of complications
- timeFrame
- 5 years
- description
- estimating the rate of complications (Clavien-Dindo grades III - IV) attributable to the TULSA Procedure
- measure
- Freedom from treatment failure
- timeFrame
- 5 years
- description
- Estimating the proportion of patients who are free from primary treatment failure after the TULSA Procedure.
Secondary outcomes (18)
- measure
- Complications Data
- timeFrame
- Lifelong up to 99 years
- description
- complications arising from TULSA-PRO treatment, categorized based on the type of corrective therapy needed using the Clavien-Dindo classification system
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria 1. Male 2. \>18 years old 3. Candidate for TULSA-PRO treatment 4. willing and able to sign the Informed Consent form Exclusion Criteria: None.
References
Publications (0)
Data not yet available
No reference posted for this study.